Skip to content

Mycophenolate Mofetil

Mycophenolate Mofetil (Cellcept) is an immunosuppressant used to prevent organ transplant rejection. This listing covers the single capsule formulation of this medicine in the catalogue.

Medicine containing Mycophenolate Mofetil

Cellcept

Organ Transplant Rejection

250mg · 500mg

Mycophenolate mofetil capsules for preventing organ transplant rejection. It targets lymphocytes specifically, reducing the risk of the body attacking the new organ.

From$2.91/ capsuleView

Key points

  • Mycophenolate Mofetil is an immunosuppressant that prevents the immune system from attacking a transplanted organ.
  • Cellcept is the originator brand from Roche, available in 250mg and 500mg capsules.
  • Mycophenolate is grouped under autoimmune support, covering medicines that help manage immune-related conditions.

This medicine, Mycophenolate Mofetil, is listed for (Organ Transplant Rejection). Mycophenolate is taken as part of a treatment plan to aid the body in accepting a transplanted organ.

Further reading